Trials / Unknown
UnknownNCT05807672
Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer
MARF-E- Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this context, the aim of this study is to investigate the role of MRF in endometrial cancer. Several applications are possible. Firstly, T1-, T2- and DWI-mappings can be associated to molecular risk group classification, in order to stratify patients' risk without recurring to surgery. MRF parameters can be also correlated to prognosis, both in terms of disease-free survival (DFS) and overall survival (OS).
Conditions
Timeline
- Start date
- 2022-04-23
- Primary completion
- 2025-04-30
- Completion
- 2025-12-31
- First posted
- 2023-04-11
- Last updated
- 2023-04-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05807672. Inclusion in this directory is not an endorsement.